Last reviewed · How we verify
NCT06075732
ACTIVATE in Public Housing
NA trial testing Increasing Willingness and Uptake of Influenza, Pneumonia, Meningitis, HZV, and COVID-19 Vaccination in Pneumonia in 400 participants. Completed in 2 December 2024.
30 November 2024
Quick facts
| Lead sponsor | Charles Drew University of Medicine and Science |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 400 |
| Start date | 1 July 2024 |
| Primary completion | 30 November 2024 |
| Estimated completion | 2 December 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Increasing Willingness and Uptake of Influenza, Pneumonia, Meningitis, HZV, and COVID-19 Vaccination
Conditions studied
- Pneumonia — all drugs for Pneumonia →
- Influenza — all drugs for Influenza →
- Varicella Zoster — all drugs for Varicella Zoster →
- Meningitis — all drugs for Meningitis →
Sponsor
Charles Drew University of Medicine and Science
Who can join
18 and older, any sex, with Pneumonia or Influenza. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This multilevel, multidisciplinary, theoretically based, culturally sensitive, community-engaged intervention sets out to mitigate uptake barriers and non-adherence to vaccination schedules as recommended by the CDC and increase influenza, meningitis, pneumonia, VZV, and COVID-19 vaccine rates among under-resourced African American and Latino public housing residents in South Los Angeles.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06075732
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pneumonia
Currently open trials in the same condition.
- NCT07453966 — Efficacy and Safety of Intrapulmonary Percussive Ventilation in Patients With Pulmonary Infection Receiving Invasive Mec · NA · recruiting
- NCT07251465 — A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting Pneumonia · active not recruiting
- NCT07311343 — Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia · Phase 4 · recruiting
- NCT07298889 — High PEEP in Noninvasive Ventilation Patients With Pneumonia or ARDS · NA · recruiting
- NCT06911658 — Infectious Complications After Esophagectomy · recruiting
Other Charles Drew University of Medicine and Science trials
Trials by the same sponsor.
- NCT05605028 — A Mental Health Intervention for a Community Program Called the PowerObesity · NA · withdrawn
- NCT04542395 — COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents · NA · withdrawn
- NCT05805306 — Entre Herman@s: Promoting Health Among Latino MSM · NA · completed
- NCT05471141 — Preventing and Managing Cognitive Impairment · NA · withdrawn
- NCT04761692 — Increasing COVID-19, Influenza, and Pneumonia Vaccine Uptake · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06075732 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Charles Drew University of Medicine and Science
- Last refreshed: 17 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06075732.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing